SCHEMBL5476374

SCHEMBL5476374

CCc1cccc(NS(=O)(=O)N2CCCCCC2)n1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HPGD P15428 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HSD17B10 Q99714 1/20 0.46
FKBP1A P62942 8/20 0.46
HSD11B1 P28845 2/20 0.45
MAPK1 P28482 2/20 0.43
HTT P42858 2/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 2/20 0.42
GLA P06280 1/20 0.42
CXCR2 P25025 2/20 0.40
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38
CRHBP P24387 1/20 0.38
CRHR2 Q13324 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5473684 1.00 ALDH1A1 (0.46) ALDH1A1HPGDKDM4EHSD17B10FKBP1A
SCHEMBL14581869 0.85 ALDH1A1 (0.44) ALDH1A1KDM4EHSD11B1MAPK1HTT
SCHEMBL14581789 0.85 HSD11B1 (0.43) ALDH1A1HPGDKDM4EHSD17B10HSD11B1
SCHEMBL5481988 0.85 HSD11B1 (0.43) ALDH1A1HSD11B1LMNAKMT2AMEN1
SCHEMBL14581868 0.84 HSD11B1 (0.42) ALDH1A1HPGDKDM4EHSD17B10HSD11B1
SCHEMBL5471117 0.84 POLB (0.42) ALDH1A1HPGDKDM4EHSD17B10HSD11B1
SCHEMBL5471314 0.84 LMNA (0.44) ALDH1A1KDM4EHSD11B1MAPK1HTT
SCHEMBL5468253 0.83 HSD11B1 (0.39) ALDH1A1HPGDKDM4EHSD17B10FKBP1A
SCHEMBL5468378 0.83 USP5 (0.42) ALDH1A1HPGDKDM4EHSD17B10HSD11B1
SCHEMBL5473662 0.82 HSD11B1 (0.41) HSD11B1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives AGOURON PHARMACEUTICALS, INC 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027118-A1 Novel compounds of amino sulfonyl derivatives HSD11B1, HSD11B2, HSD17B11 ALDH1A1 74/4885HPGD 385/4885KDM4E 1163/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.